{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:41:29Z","timestamp":1790847689278,"version":"4.1.0"},"reference-count":183,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,3,21]],"date-time":"2019-03-21T00:00:00Z","timestamp":1553126400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004635","name":"Fru Berta Kamprads Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004635","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["2015K1A1A2028365"],"award-info":[{"award-number":["2015K1A1A2028365"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["2016K2A9A1A03904900"],"award-info":[{"award-number":["2016K2A9A1A03904900"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIH\/NCI International Cancer Proteogenome Consortium","award":["MOU NIH-LUND 2017-01"],"award-info":[{"award-number":["MOU NIH-LUND 2017-01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biol Toxicol"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s10565-019-09468-6","type":"journal-article","created":{"date-parts":[[2019,3,21]],"date-time":"2019-03-21T08:18:01Z","timestamp":1553156281000},"page":"293-332","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Clinical protein science in translational medicine targeting malignant melanoma"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3601-3893","authenticated-orcid":false,"given":"Jeovanis","family":"Gil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lazaro Hiram","family":"Betancourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indira","family":"Pla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aniel","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Appelqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasso","family":"Miliotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Kuras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henriette","family":"Oskolas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghyo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsolt","family":"Horvath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonatan","family":"Eriksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan","family":"Berge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Burestedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6ran","family":"J\u00f6nsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Baldetorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Ingvar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e5kan","family":"Olsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lotta","family":"Lundgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Horvatovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimmy Rodriguez","family":"Murillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Sugihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Welinder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabet","family":"Wieslander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boram","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Lindberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Paw\u0142owski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho Jeong","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktoria","family":"Doma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jozsef","family":"Timar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarolta","family":"Karpati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Marcell","family":"Szasz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Istv\u00e1n Bal\u00e1zs","family":"N\u00e9meth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihide","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garry","family":"Corthals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda","family":"Rezeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Knudsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Malm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gy\u00f6rgy","family":"Marko-Varga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,21]]},"reference":[{"key":"9468_CR1","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1074\/mcp.M116.058354","volume":"15","author":"JG Abelin","year":"2016","unstructured":"Abelin JG, Patel J, Lu X, Feeney CM, Fagbami L, Creech AL, et al. Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes. Mol Cell Proteomics. 2016;15:1622\u201341.","journal-title":"Mol Cell Proteomics"},{"key":"9468_CR2","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/nchembio.2576","volume":"14","author":"R Aebersold","year":"2018","unstructured":"Aebersold R, Agar JN, Amster IJ, Baker MS, Bertozzi CR, Boja ES, et al. How many human proteoforms are there? Nat Chem Biol. 2018;14:206\u201314.","journal-title":"Nat Chem Biol"},{"key":"9468_CR3","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1016\/j.cell.2015.05.044","volume":"161","author":"R Akbani","year":"2015","unstructured":"Akbani R, Akdemir KC, Aksoy BA, Albert M, Ally A, Amin SB, et al. Genomic classification of cutaneous melanoma. Cell. 2015;161:1681\u201396.","journal-title":"Cell"},{"key":"9468_CR4","doi-asserted-by":"publisher","unstructured":"Alexandrov T. MALDI imaging mass spectrometry: statistical data analysis and current computational challenges. BMC Bioinformatics. 2012;13 Suppl 16:S11. https:\/\/doi.org\/10.1186\/1471-2105-13-S16-S11 .","DOI":"10.1186\/1471-2105-13-S16-S11"},{"key":"9468_CR5","doi-asserted-by":"publisher","first-page":"3450","DOI":"10.1158\/0008-5472.CAN-06-3481","volume":"67","author":"SR Alonso","year":"2007","unstructured":"Alonso SR, Tracey L, Ortiz P, P\u00e9rez-G\u00f3mez B, Palacios J, Poll\u00e1n M, et al. A high-throughput study in melanoma identifies epithelial-mesenchymal transition as a major determinant of metastasis. Cancer Res. 2007;67:3450\u201360.","journal-title":"Cancer Res"},{"key":"9468_CR6","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3892\/ijmm.2017.3036","volume":"40","author":"F Ardito","year":"2017","unstructured":"Ardito F, Giuliani M, Perrone D, Troiano G, Lo ML. The crucial role of protein phosphorylation in cell signaling and its use as targeted therapy (review). Int J Mol Med. 2017;40:271\u201380.","journal-title":"Int J Mol Med"},{"key":"9468_CR7","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/sj.bjc.6606030","volume":"104","author":"HT Arkenau","year":"2011","unstructured":"Arkenau HT, Kefford R, Long GV. Targeting BRAF for patients with melanoma. Br J Cancer. 2011;104:392\u20138.","journal-title":"Br J Cancer"},{"issue":"8","key":"9468_CR8","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/nrd4090","volume":"12","author":"J Arrowsmith","year":"2013","unstructured":"Arrowsmith J, Miller P. Trial watch: phase ii and phase III attrition rates 2011\u20132012. Nat Rev Drug Discov. 2013. Nature Publishing Group;12(8):569.","journal-title":"Nat Rev Drug Discov"},{"key":"9468_CR9","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.humpath.2014.11.006","volume":"46","author":"PP Aung","year":"2015","unstructured":"Aung PP, Leone D, Feller JK, Yang S, Hernandez M, Yaar R, et al. Microvessel density, lymphovascular density, and lymphovascular invasion in primary cutaneous melanoma - Correlation with histopathologic prognosticators and BRAF status. Hum Pathol. 2015;46:304\u201312.","journal-title":"Hum Pathol"},{"key":"9468_CR10","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1074\/mcp.RA117.000335","volume":"17","author":"J Basken","year":"2018","unstructured":"Basken J, Stuart SA, Kavran AJ, Lee T, Ebmeier CC, Old WM, et al. Specificity of phosphorylation responses to mitogen activated protein (MAP) kinase pathway inhibitors in melanoma cells. Mol Cell Proteomics. 2018;17:550\u201364.","journal-title":"Mol Cell Proteomics"},{"key":"9468_CR11","doi-asserted-by":"publisher","first-page":"6176","DOI":"10.1021\/pr500893m","volume":"13","author":"TS Batth","year":"2014","unstructured":"Batth TS, Francavilla C, Olsen JV. Off-line high-pH reversed-phase fractionation for in-depth phosphoproteomics. J Proteome Res. 2014;13:6176\u201386.","journal-title":"J Proteome Res"},{"key":"9468_CR12","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/j.1755-148X.2011.00837.x","volume":"24","author":"J Bauer","year":"2011","unstructured":"Bauer J, B\u00fcttner P, Murali R, Okamoto I, Kolaitis NA, Landi MT, et al. BRAF mutations in cutaneous melanoma are independently associated with age, anatomic site of the primary tumor, and the degree of solar elastosis at the primary tumor site. Pigment Cell Melanoma Res. 2011;24:345\u201351.","journal-title":"Pigment Cell Melanoma Res"},{"key":"9468_CR13","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1093\/bioinformatics\/btv146","volume":"31","author":"KD Bemis","year":"2015","unstructured":"Bemis KD, Harry A, Eberlin LS, Ferreira C, Van De Ven SM, Mallick P, et al. Cardinal: an R package for statistical analysis of mass spectrometry-based imaging experiments. Bioinformatics. 2015;31:2418\u201320.","journal-title":"Bioinformatics"},{"key":"9468_CR14","doi-asserted-by":"publisher","unstructured":"Bersanelli M, Mosca E, Remondini D, Giampieri E, Sala C, Castellani G, et al. Methods for the integration of multi-omics data: mathematical aspects. BMC Bioinformatics. 2016;17 Suppl 2:15. https:\/\/doi.org\/10.1186\/s12859-015-0857-9 .","DOI":"10.1186\/s12859-015-0857-9"},{"key":"9468_CR15","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00216-008-1865-7","volume":"391","author":"PJ Boersema","year":"2008","unstructured":"Boersema PJ, Mohammed S, Heck AJR. Hydrophilic interaction liquid chromatography (HILIC) in proteomics. Anal Bioanal Chem. 2008;391:151\u20139.","journal-title":"Anal Bioanal Chem"},{"key":"9468_CR16","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1097\/00000658-197011000-00017","volume":"172","author":"A Breslow","year":"1970","unstructured":"Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg. 1970;172:902\u20138.","journal-title":"Ann Surg"},{"key":"9468_CR17","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1111\/j.1755-148X.2010.00778.x","volume":"23","author":"SMC Broekaert","year":"2010","unstructured":"Broekaert SMC, Roy R, Okamoto I, Van Den Oord J, Bauer J, Garbe C, et al. Genetic and morphologic features for melanoma classification. Pigment Cell Melanoma Res. 2010;23:763\u201370.","journal-title":"Pigment Cell Melanoma Res"},{"issue":"7\u20138","key":"9468_CR18","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1159\/000478893","volume":"40","author":"K Buder-Bakhaya","year":"2017","unstructured":"Buder-Bakhaya K, Machiraju D, Hassel JC. Liquid biopsy: value for melanoma therapy. Oncol Res Treat. 2017;40(7\u20138):430\u20134.","journal-title":"Oncol Res Treat"},{"key":"9468_CR19","doi-asserted-by":"publisher","first-page":"3446","DOI":"10.1002\/cncr.28864","volume":"120","author":"M Burotto","year":"2014","unstructured":"Burotto M, Chiou VL, Lee JM, Kohn EC. The MAPK pathway across different malignancies: a new perspective. Cancer. 2014;120:3446\u201356.","journal-title":"Cancer."},{"key":"9468_CR20","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1053\/j.semdp.2013.11.002","volume":"30","author":"KJ Busam","year":"2013","unstructured":"Busam KJ. Molecular pathology of melanocytic tumors. Semin Diagn Pathol. 2013;30:362\u201374.","journal-title":"Semin Diagn Pathol"},{"key":"9468_CR21","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.canlet.2017.06.030","volume":"404","author":"L Calapre","year":"2017","unstructured":"Calapre L, Warburton L, Millward M, Ziman M, Gray ES. Circulating tumour DNA (ctDNA) as a liquid biopsy for melanoma. Cancer Lett. 2017;404:62\u20139.","journal-title":"Cancer Lett"},{"key":"9468_CR22","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.ccr.2013.08.018","volume":"24","author":"J Caramel","year":"2013","unstructured":"Caramel J, Papadogeorgakis E, Hill L, Browne GJ, Richard G, Wierinckx A, et al. A Switch in the Expression of Embryonic EMT-Inducers Drives the Development of Malignant Melanoma. Cancer Cell. 2013;24:466\u201380.","journal-title":"Cancer Cell"},{"key":"9468_CR23","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","volume":"364","author":"PB Chapman","year":"2011","unstructured":"Chapman PB, Hauschild A, Robert C, Haanen JB, Ascierto P, Larkin J, et al. Improved survival with Vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med. 2011;364:2507\u201316.","journal-title":"N Engl J Med"},{"key":"9468_CR24","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1056\/NEJMc1501894","volume":"372","author":"PB Chapman","year":"2015","unstructured":"Chapman PB, D\u2019Angelo SP, Wolchok JD. Rapid eradication of a bulky melanoma mass with one dose of immunotherapy. N Engl J Med. 2015;372:2073\u20134.","journal-title":"N Engl J Med"},{"issue":"1","key":"9468_CR25","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40246-018-0142-x","volume":"12","author":"G Charkoftaki","year":"2018","unstructured":"Charkoftaki G, Rattray NJW, Andr\u00e9n PE, Caprioli RM, Castellino S, Duncan MW, et al. Yale School of Public Health Symposium on tissue imaging mass spectrometry: illuminating phenotypic heterogeneity and drug disposition at the molecular level. Hum Genomics BioMed Central. 2018;12(1):10.","journal-title":"Hum Genomics"},{"issue":"4","key":"9468_CR26","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1021\/pr025517j","volume":"1","author":"D Chelius","year":"2002","unstructured":"Chelius D, Bondarenko PV. Quantitative profiling of proteins in complex mixtures using liquid chromatography and mass spectrometry. J Proteome Res. 2002;1(4):317\u201323.","journal-title":"J Proteome Res"},{"key":"9468_CR27","doi-asserted-by":"publisher","unstructured":"Chiappetta C, Proietti I, Soccodato V, Puggioni C, Zaralli R, Pacini L, et al. BRAF and NRAS mutations are heterogeneous and not mutually exclusive in nodular melanoma. Appl Immunohistochem Mol Morphol. 2015;(3):172\u20137. https:\/\/doi.org\/10.1097\/PAI.0000000000000071 .","DOI":"10.1097\/PAI.0000000000000071"},{"issue":"8","key":"9468_CR28","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1007\/s00216-014-8350-2","volume":"407","author":"JJ Connell","year":"2015","unstructured":"Connell JJ, Sugihara Y, T\u00f6r\u00f6k S, D\u00f6me B, T\u00f3v\u00e1ri J, Fehniger TE, et al. Localization of sunitinib in in vivo animal and in vitro experimental models by MALDI mass spectrometry imaging. Anal Bioanal Chem. 2015;407(8):2245\u201353.","journal-title":"Anal Bioanal Chem"},{"issue":"6","key":"9468_CR29","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/nrd4309","volume":"13","author":"D Cook","year":"2014","unstructured":"Cook D, Brown D, Alexander R, March R, Morgan P, Satterthwaite G, et al. Lessons learned from the fate of AstraZeneca\u2019s drug pipeline: a five-dimensional framework. Nat Rev Drug Discov. 2014;13(6):419\u201331.","journal-title":"Nat Rev Drug Discov"},{"issue":"10","key":"9468_CR30","doi-asserted-by":"publisher","first-page":"565","DOI":"10.2131\/jts.43.565","volume":"43","author":"JC Cook","year":"2018","unstructured":"Cook JC, Wu H, Aleo MD, Adkins K. Principles of precision medicine and its application in toxicology. J Toxicol Sci The Japanese Society of Toxicology. 2018;43(10):565\u201377.","journal-title":"J Toxicol Sci"},{"issue":"4","key":"9468_CR31","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/labinvest.2014.153","volume":"95","author":"LA Cooper","year":"2015","unstructured":"Cooper LA, Kong J, Gutman DA, Dunn WD, Nalisnik M, Brat DJ. Novel genotype-phenotype associations in human cancers enabled by advanced molecular platforms and computational analysis of whole slide images. Lab Investig. 2015;95(4):366\u201376.","journal-title":"Lab Investig"},{"issue":"20","key":"9468_CR32","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1056\/NEJMoa050092","volume":"353","author":"JA Curtin","year":"2005","unstructured":"Curtin JA, Fridlyand J, Kageshita T, Patel HN, Busam KJ, Kutzner H, et al. Distinct sets of genetic alterations in melanoma. N Engl J Med. 2005;353(20):2135\u201347.","journal-title":"N Engl J Med"},{"issue":"26","key":"9468_CR33","doi-asserted-by":"publisher","first-page":"4340","DOI":"10.1200\/JCO.2006.06.2984","volume":"24","author":"JA Curtin","year":"2006","unstructured":"Curtin JA, Busam K, Pinkel D, Bastian BC. Somatic activation of KIT in distinct subtypes of melanoma. J Clin Oncol. 2006;24(26):4340\u20136.","journal-title":"J Clin Oncol"},{"key":"9468_CR34","doi-asserted-by":"crossref","unstructured":"Dagogo-Jack I, Azzolli GC, Fintelmann F, Mino-Kenudson M, Farago AF, Gainor JF, et al. Clinical Utility of Rapid Genotyping in Advanced Lung Cancer. JCO Precision Oncology 2018;(2):1\u201313.","DOI":"10.1200\/PO.17.00299"},{"key":"9468_CR35","doi-asserted-by":"crossref","unstructured":"De Graaf EL, Pellegrini D, McDonnell LA. Set of novel automated quantitative microproteomics protocols for small sample amounts and its application to kidney tissue substructures. J Proteome Res. 2016;15(12):4722\u201330.","DOI":"10.1021\/acs.jproteome.6b00889"},{"key":"9468_CR36","doi-asserted-by":"publisher","unstructured":"de Lange MJ, Nell RJ, Lalai RN, Versluis M, Jordanova ES, Luyten GPM, et al. Digital PCR-based T-cell quantification-assisted deconvolution of the microenvironment reveals that activated macrophages drive tumor inflammation in uveal melanoma. Mol Cancer Res. 2018;16(12):1902\u201311. https:\/\/doi.org\/10.1158\/1541-7786.MCR-18-0114 .","DOI":"10.1158\/1541-7786.MCR-18-0114"},{"issue":"14","key":"9468_CR37","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1093\/bioinformatics\/bty148","volume":"34","author":"C Dimitrakopoulos","year":"2018","unstructured":"Dimitrakopoulos C, Hindupur SK, H\u00e4fliger L, Behr J, Montazeri H, Hall MN, et al. Network-based integration of multi-omics data for prioritizing cancer genes. Birol I, editor. Bioinformatics. 2018;34(14):2441\u20138.","journal-title":"Bioinformatics."},{"key":"9468_CR38","doi-asserted-by":"publisher","unstructured":"Dimitriou F, Krattinger R, Ramelyte E, Barysch MJ, Micaletto S, Dummer R, et al. The world of melanoma: epidemiologic, genetic, and anatomic differences of melanoma across the globe. Curr Oncol Rep. 2018;20(11):87. https:\/\/doi.org\/10.1007\/s11912-018-0732-8 .","DOI":"10.1007\/s11912-018-0732-8"},{"key":"9468_CR39","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1111\/j.1755-148X.2011.00871.x","volume":"24","author":"OM Eichhoff","year":"2011","unstructured":"Eichhoff OM, Weeraratna A, Zipser MC, Denat L, Widmer DS, Xu M, et al. Differential LEF1 and TCF4 expression is involved in melanoma cell phenotype switching. Pigment Cell Melanoma Res. 2011;24:631\u201342.","journal-title":"Pigment Cell Melanoma Res"},{"key":"9468_CR40","doi-asserted-by":"crossref","unstructured":"El Ghissassi F, Baan R, Straif K, Grosse Y, Secretan B, Bouvard V, et al. A review of human carcinogens\u2014part D: radiation. Lancet Oncol. 2009;10(8):751\u20132.","DOI":"10.1016\/S1470-2045(09)70213-X"},{"issue":"2","key":"9468_CR41","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1097\/DAD.0b013e318165641a","volume":"30","author":"PO Emanuel","year":"2008","unstructured":"Emanuel PO, Mannion M, Phelps RG. Complete regression of primary malignant melanoma. Am J Dermatopathol. 2008;30(2):178\u201381.","journal-title":"Am J Dermatopathol"},{"key":"9468_CR42","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1586\/era.10.170","volume":"10","author":"E Erdei","year":"2010","unstructured":"Erdei E, Torres SM. A new understanding in the epidemiology of melanoma. Expert Rev Anticancer Ther. 2010;10:1811\u201323.","journal-title":"Expert Rev Anticancer Ther"},{"issue":"7688","key":"9468_CR43","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nature25187","volume":"553","author":"Z Eroglu","year":"2018","unstructured":"Eroglu Z, Zaretsky JM, Hu-Lieskovan S, Kim DW, Algazi A, Johnson DB, et al. High response rate to PD-1 blockade in desmoplastic melanomas. Nature. 2018;553(7688):347\u201350.","journal-title":"Nature."},{"key":"9468_CR44","doi-asserted-by":"publisher","unstructured":"Falzone L, Salomone S, Libra M. Evolution of cancer pharmacological treatments at the turn of the third millennium. Front Pharmacol. 2018;9:1300. https:\/\/doi.org\/10.3389\/fphar.2018.01300 .","DOI":"10.3389\/fphar.2018.01300"},{"key":"9468_CR45","doi-asserted-by":"publisher","first-page":"8329","DOI":"10.1021\/ac2014349","volume":"83","author":"TE Fehniger","year":"2011","unstructured":"Fehniger TE, V\u00e9gv\u00e1ri \u00c1, Rezeli M, Prikk K, Ross P, Dahlb\u00e4ck M, et al. Direct demonstration of tissue uptake of an inhaled drug: proof-of-principle study using matrix-assisted laser desorption ionization mass spectrometry imaging. Anal Chem. 2011;83:8329\u201336.","journal-title":"Anal Chem"},{"key":"9468_CR46","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.euprot.2013.04.001","volume":"1","author":"TE Fehniger","year":"2013","unstructured":"Fehniger TE, V\u00e9gv\u00e1ri \u00c1, Rezeli M, D\u00f6me B, T\u00edm\u00e1r J, Marko-Varga G. International biobanking for lung cancer and COPD as thefuture resource for clinical protein research. EuPA Open Proteom. 2013;1:3\u20137.","journal-title":"EuPA Open Proteom"},{"key":"9468_CR47","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, All E. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359\u201386.","journal-title":"Int J Cancer"},{"key":"9468_CR48","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1101\/gr.119867.110","volume":"22","author":"AF Fernandez","year":"2012","unstructured":"Fernandez AF, Assenov Y, Martin-Subero JI, Balint B, Siebert R, Taniguchi H, et al. A DNA methylation fingerprint of 1628 human samples. Genome Res. 2012;22:407\u201319.","journal-title":"Genome Res"},{"key":"9468_CR49","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jprot.2018.07.013","volume":"186","author":"DL Fern\u00e1ndez-Coto","year":"2018","unstructured":"Fern\u00e1ndez-Coto DL, Gil J, Hern\u00e1ndez A, Herrera-Goepfert R, Castro-Romero I, Hern\u00e1ndez-M\u00e1rquez E, et al. Quantitative proteomics reveals proteins involved in the progression from non-cancerous lesions to gastric cancer. J Proteome. 2018;186:15\u201327.","journal-title":"J Proteome"},{"key":"9468_CR50","doi-asserted-by":"publisher","unstructured":"Fitzmaurice C, Akinyemiju TF, Al Lami FH, Alam T, Alizadeh-Navaei R, Allen C, et al. Global, Regional, and National Cancer Incidence, Mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2016: A systematic analysis for the global burden of disease study. JAMA Oncol. 2018;4(11):1553\u201368. https:\/\/doi.org\/10.1001\/jamaoncol.2018.2706 .","DOI":"10.1001\/jamaoncol.2018.2706"},{"issue":"2","key":"9468_CR51","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMoa1203421","volume":"367","author":"KT Flaherty","year":"2012","unstructured":"Flaherty KT, Robert C, Hersey P, Nathan P, Garbe C, Milhem M, et al. Improved survival with MEK inhibition in BRAF-mutated melanoma. N Engl J Med. 2012;367(2):107\u201314.","journal-title":"N Engl J Med"},{"issue":"D1","key":"9468_CR52","doi-asserted-by":"publisher","first-page":"D777","DOI":"10.1093\/nar\/gkw1121","volume":"45","author":"SA Forbes","year":"2017","unstructured":"Forbes SA, Beare D, Boutselakis H, Bamford S, Bindal N, Tate J, et al. COSMIC: somatic cancer genetics at high-resolution. Nucleic Acids Res Oxford University Press. 2017;45(D1):D777\u201383.","journal-title":"Nucleic Acids Res"},{"key":"9468_CR53","doi-asserted-by":"publisher","unstructured":"Fu S, Wu H, Zhang H, Lian CG, Lu Q. DNA methylation \/ hydroxymethylation in melanoma. 2017;8(44):78163\u201373. https:\/\/doi.org\/10.18632\/oncotarget.18293 .","DOI":"10.18632\/oncotarget.18293"},{"key":"9468_CR54","doi-asserted-by":"publisher","first-page":"E2918","DOI":"10.1073\/pnas.1405601111","volume":"111","author":"JA Galan","year":"2014","unstructured":"Galan JA, Geraghty KM, Lavoie G, Kanshin E, Tcherkezian J, Calabrese V, et al. Phosphoproteomic analysis identifies the tumor suppressor PDCD4 as a RSK substrate negatively regulated by 14-3-3. Proc Natl Acad Sci. 2014;111:E2918\u201327.","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"9468_CR55","doi-asserted-by":"publisher","first-page":"4172","DOI":"10.1038\/s41467-018-06366-z","volume":"9","author":"SK Gara","year":"2018","unstructured":"Gara SK, Lack J, Zhang L, Harris E, Cam M, Kebebew E. Metastatic adrenocortical carcinoma displays higher mutation rate and tumor heterogeneity than primary tumors. Nat Commun Nature Publishing Group. 2018;9(1):4172.","journal-title":"Nat Commun"},{"issue":"7","key":"9468_CR56","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/exd.13250","volume":"26","author":"DS Gareau","year":"2017","unstructured":"Gareau DS, Correa da Rosa J, Yagerman S, Carucci JA, Gulati N, Hueto F, et al. Digital imaging biomarkers feed machine learning for melanoma screening. Exp Dermatol. 2017;26(7):615\u20138.","journal-title":"Exp Dermatol"},{"issue":"29","key":"9468_CR57","doi-asserted-by":"publisher","first-page":"11982","DOI":"10.1073\/pnas.1300136110","volume":"110","author":"MJ Gerdes","year":"2013","unstructured":"Gerdes MJ, Sevinsky CJ, Sood A, Adak S, Bello MO, Bordwell A, et al. Highly multiplexed single-cell analysis of formalin-fixed, paraffin-embedded cancer tissue. Proc Natl Acad Sci U S A. 2013;110(29):11982\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"9468_CR58","doi-asserted-by":"publisher","first-page":"472","DOI":"10.3322\/caac.21409","volume":"67","author":"JE Gershenwald","year":"2017","unstructured":"Gershenwald JE, Scolyer RA, Hess KR, Sondak VK, Long GV, Ross MI, et al. Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67(6):472\u201392.","journal-title":"CA Cancer J Clin"},{"key":"9468_CR59","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jprot.2014.03.021","volume":"107","author":"MM Gessel","year":"2014","unstructured":"Gessel MM, Norris JL, Caprioli RM. MALDI imaging mass spectrometry: spatial molecular analysis to enable a new age of discovery. J Proteome. 2014;107:71\u201382.","journal-title":"J Proteome"},{"issue":"4","key":"9468_CR60","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nmeth.2869","volume":"11","author":"C Giesen","year":"2014","unstructured":"Giesen C, Wang HAO, Schapiro D, Zivanovic N, Jacobs A, Hattendorf B, et al. Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry. Nat Methods. 2014;11(4):417\u201322.","journal-title":"Nat Methods"},{"issue":"44","key":"9468_CR61","doi-asserted-by":"publisher","first-page":"18129","DOI":"10.1074\/jbc.M117.784546","volume":"292","author":"J Gil","year":"2017","unstructured":"Gil J, Ram\u00edrez-Torres A, Chiappe D, Luna-Pen\u00e3loza J, Fernandez-Reyes FC, Arcos-Encarnaci\u00f3n B, et al. Lysine acetylation stoichiometry and proteomics analyses reveal pathways regulated by sirtuin 1 in human cells. J Biol Chem. 2017;292(44):18129\u201344.","journal-title":"J Biol Chem"},{"issue":"2","key":"9468_CR62","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1001\/jamadermatol.2016.4512","volume":"153","author":"AM Glazer","year":"2017","unstructured":"Glazer AM, Winkelmann RR, Farberg AS, Rigel DS. Analysis of trends in US melanoma incidence and mortality. JAMA Dermatol American Medical Association. 2017;153(2):225.","journal-title":"JAMA Dermatol"},{"issue":"4","key":"9468_CR63","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.cell.2018.07.010","volume":"174","author":"Y Goltsev","year":"2018","unstructured":"Goltsev Y, Samusik N, Kennedy-Darling J, Bhate S, Hale M, Vazquez G, et al. Deep profiling of mouse splenic architecture with CODEX multiplexed imaging. Cell. 2018;174(4):968\u2013981.e15.","journal-title":"Cell"},{"key":"9468_CR64","doi-asserted-by":"crossref","first-page":"42008","DOI":"10.18632\/oncotarget.5788","volume":"6","author":"ES Gray","year":"2015","unstructured":"Gray ES, Rizos H, Reid AL, Boyd SC, Pereira MR, Lo J, et al. Circulating tumor DNA to monitor treatment response and detect acquired resistance in patients with metastatic melanoma. Oncotarget. 2015;6:42008\u201318.","journal-title":"Oncotarget"},{"key":"9468_CR65","first-page":"7356","volume":"2018","author":"Y Guo","year":"2018","unstructured":"Guo Y, Long J, Lei S. Promoter methylation as biomarkers for diagnosis of melanoma: a systematic review and meta-analysis. J Cell Physiol. 2018;2018:7356\u201367.","journal-title":"J Cell Physiol"},{"issue":"8","key":"9468_CR66","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1093\/annonc\/mdy166","volume":"29","author":"HA Haenssle","year":"2018","unstructured":"Haenssle HA, Fink C, Schneiderbauer R, Toberer F, Buhl T, Blum A, et al. Man against machine: diagnostic performance of a deep learning convolutional neural network for dermoscopic melanoma recognition in comparison to 58 dermatologists. Ann Oncol. 2018;29(8):1836\u201342.","journal-title":"Ann Oncol"},{"issue":"2","key":"9468_CR67","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.lungcan.2014.04.009","volume":"85","author":"J-Y Han","year":"2014","unstructured":"Han J-Y, Kim SH, Lee Y-S, Lee S-Y, Hwang J-A, Kim JY, et al. Comparison of targeted next-generation sequencing with conventional sequencing for predicting the responsiveness to epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) therapy in never-smokers with lung adenocarcinoma. Lung Cancer. 2014;85(2):161\u20137.","journal-title":"Lung Cancer"},{"issue":"5","key":"9468_CR68","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646\u201374.","journal-title":"Cell."},{"key":"9468_CR69","doi-asserted-by":"crossref","unstructured":"Hauschild A, Grob JJ, Demidov LV, Jouary T, Gutzmer R, Millward M, et al. Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial. The Lancet. 2012;380(9839):358\u201365.","DOI":"10.1016\/S0140-6736(12)60868-X"},{"key":"9468_CR70","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.molonc.2011.07.001","volume":"5","author":"T Helleday","year":"2011","unstructured":"Helleday T. The underlying mechanism for the PARP and BRCA synthetic lethality: clearing up the misunderstandings. Mol Oncol. 2011;5:387\u201393.","journal-title":"Mol Oncol"},{"key":"9468_CR71","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1158\/0008-5472.CAN-07-2491","volume":"68","author":"KS Hoek","year":"2008","unstructured":"Hoek KS, Eichhoff OM, Schlegel NC, D\u00f6bbeling U, Kobert N, Schaerer L, et al. In vivo switching of human melanoma cells between proliferative and invasive states. Cancer Res. 2008;68:650\u20136.","journal-title":"Cancer Res"},{"key":"9468_CR72","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3389\/fgene.2017.00084","volume":"8","author":"S Huang","year":"2017","unstructured":"Huang S, Chaudhary K, Garmire LX. More is better: recent progress in multi-omics data integration methods. Front Genet Frontiers Media SA. 2017;8:84.","journal-title":"Front Genet"},{"key":"9468_CR73","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1200\/JCO.2013.52.1377","volume":"32","author":"S Hu-Lieskovan","year":"2014","unstructured":"Hu-Lieskovan S, Robert L, Moreno BH, Ribas A. Combining targeted therapy with immunotherapy in BRAF-mutant melanoma: promise and challenges. J Clin Oncol. 2014;32:2248\u201354.","journal-title":"J Clin Oncol"},{"key":"9468_CR74","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/0092-8674(95)90405-0","volume":"80","author":"T Hunter","year":"1995","unstructured":"Hunter T. Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling. Cell. 1995;80:225\u201336.","journal-title":"Cell."},{"key":"9468_CR75","doi-asserted-by":"publisher","unstructured":"Hwang WL, Wolfson RL, Niemierko A, Marcus KJ, DuBois SG, Haas-Kogan D. Clinical Impact of Tumor Mutational Burden in Neuroblastoma. J Natl Cancer Inst. 2018. https:\/\/doi.org\/10.1093\/jnci\/djy157 .","DOI":"10.1093\/jnci\/djy157"},{"key":"9468_CR76","unstructured":"IARC. Latest Global Cancer Data, 2018. World Heal. Organ. 2018."},{"issue":"1","key":"9468_CR77","doi-asserted-by":"publisher","first-page":"13190","DOI":"10.1038\/s41598-017-13196-4","volume":"7","author":"N Ing","year":"2017","unstructured":"Ing N, Huang F, Conley A, You S, Ma Z, Klimov S, et al. A novel machine learning approach reveals latent vascular phenotypes predictive of renal cancer outcome. Sci Rep. 2017;7(1):13190.","journal-title":"Sci Rep"},{"key":"9468_CR78","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.lungcan.2018.07.039","volume":"124","author":"Y Jin","year":"2018","unstructured":"Jin Y, Shi X, Zhao J, He Q, Chen M, Yan J, et al. Mechanisms of primary resistance to EGFR targeted therapy in advanced lung adenocarcinomas. Lung Cancer Elsevier. 2018;124:110\u20136.","journal-title":"Lung Cancer"},{"key":"9468_CR79","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nrg816","volume":"3","author":"PA Jones","year":"2002","unstructured":"Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet. 2002;3:415\u201328.","journal-title":"Nat Rev Genet"},{"key":"9468_CR80","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1016\/j.ejca.2004.04.036","volume":"40","author":"A Karpozilos","year":"2004","unstructured":"Karpozilos A, Pavlidis N. The treatment of cancer in Greek antiquity. Eur J Cancer. 2004;40:2033\u201340.","journal-title":"Eur J Cancer"},{"issue":"1","key":"9468_CR81","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1021\/pr100859b","volume":"10","author":"H Kato","year":"2011","unstructured":"Kato H, Nishimura T, Hirano T, Nomura M, Tojo H, Fujii K, et al. A clinician view and experience of proteomic studies in the light of lung cancer in Japanese healthcare. J Proteome Res American Chemical Society. 2011;10(1):51\u20137.","journal-title":"J Proteome Res"},{"issue":"3","key":"9468_CR82","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1136\/jcp.2007.049411","volume":"61","author":"C Kaur","year":"2007","unstructured":"Kaur C, Thomas RJ, Desai N, Green MA, Lovell D, Powell BWEM, et al. The correlation of regression in primary melanoma with sentinel lymph node status. J Clin Pathol. 2007;61(3):297\u2013300.","journal-title":"J Clin Pathol"},{"key":"9468_CR83","doi-asserted-by":"publisher","first-page":"5937","DOI":"10.1158\/0008-5472.CAN-14-1174","volume":"74","author":"K Kemper","year":"2014","unstructured":"Kemper K, De Goeje PL, Peeper DS, Van Amerongen R. Phenotype switching: tumor cell plasticity as a resistance mechanism and target for therapy. Cancer Res. 2014;74:5937\u201341.","journal-title":"Cancer Res"},{"key":"9468_CR84","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1111\/bjd.16892","volume":"179","author":"SG Keohane","year":"2018","unstructured":"Keohane SG, Proby CM, Newlands C, Motley RJ, Nasr I, Mohd Mustapa MF, et al. The new 8th edition of TNM staging and its implications for skin cancer: a review by the British Association of Dermatologists and the Royal College of Pathologists, U.K. Br J Dermatol. 2018;179:824\u20138.","journal-title":"Br J Dermatol"},{"issue":"7502","key":"9468_CR85","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/nature13302","volume":"509","author":"MS Kim","year":"2014","unstructured":"Kim MS, Pinto SM, Getnet D, Nirujogi RS, Manda SS, Chaerkady R, et al. A draft map of the human proteome. Nature. 2014;509(7502):575\u201381.","journal-title":"Nature."},{"key":"9468_CR86","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1101\/gr.091447.109","volume":"19","author":"Y Koga","year":"2009","unstructured":"Koga Y, Pelizzola M, Cheng E, Krauthammer M, Sznol M, Ariyan S, et al. Genome-wide screen of promoter methylation identifies novel markers in melanoma. Genome Res. 2009;19:1462\u201370.","journal-title":"Genome Res"},{"issue":"10","key":"9468_CR87","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1158\/0008-5472.CAN-15-2680","volume":"76","author":"A Krumm","year":"2016","unstructured":"Krumm A, Barckhausen C, Kucuk P, Tomaszowski KH, Loquai C, Fahrer J, et al. Enhanced histone deacetylase activity in malignant melanoma provokes RAD51 and FANCD2-triggered drug resistance. Cancer Res. 2016;76(10):3067\u201377.","journal-title":"Cancer Res"},{"key":"9468_CR88","unstructured":"Kuras M, Betancourt LH, Rezeli M, Rodriguez J, Szasz M, Zhou Q, et al. Assessing Automated Sample Preparation Technologies for High-Throughput Proteomics of Frozen Well Characterized Tissues from Swedish Biobanks. J Proteome Res. 2019;18(1):548\u2013556."},{"key":"9468_CR89","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1007\/s12272-015-0627-2","volume":"38","author":"HJ Kwon","year":"2015","unstructured":"Kwon HJ, Kim Y, Sugihara Y, Baldetorp B, Welinder C, Watanabe KI, et al. Drug compound characterization by mass spectrometry imaging in cancer tissue. Arch Pharm Res. 2015;38:1718\u201327.","journal-title":"Arch Pharm Res"},{"issue":"1","key":"9468_CR90","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1056\/NEJMoa1504030","volume":"373","author":"J Larkin","year":"2015","unstructured":"Larkin J, Chiarion-Sileni V, Gonzalez R, Jacques Grob J, Lao CD, Schadendorf D, et al. Combined nivolumab and ipilimumab or monotherapy in previously untreated melanoma corresponding authors. N Engl J Med. 2015;373(1):23\u201334.","journal-title":"N Engl J Med"},{"key":"9468_CR91","doi-asserted-by":"publisher","unstructured":"Leonardi GC, Falzone L, Salemi R, Zangh\u00ec A, Spandidos DA, Mccubrey JA, et al. Cutaneous melanoma: from pathogenesis to therapy (review). Int J Oncol. 2018;52(4):1071\u201380. https:\/\/doi.org\/10.3892\/ijo.2018.4287 .","DOI":"10.3892\/ijo.2018.4287"},{"issue":"3","key":"9468_CR92","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/humu.21176","volume":"31","author":"J Li","year":"2010","unstructured":"Li J, Duncan DT, Zhang B. CanProVar: a human cancer proteome variation database. Hum Mutat. 2010;31(3):219\u201328.","journal-title":"Hum Mutat"},{"key":"9468_CR93","doi-asserted-by":"publisher","unstructured":"Li FZ, Dhillon AS, Anderson RL, McArthur G, Ferrao PT. Phenotype switching in melanoma: implications for progression and therapy. Front Oncol. 2015;5:31. https:\/\/doi.org\/10.3389\/fonc.2015.00031 .","DOI":"10.3389\/fonc.2015.00031"},{"issue":"D1","key":"9468_CR94","doi-asserted-by":"publisher","first-page":"D1039","DOI":"10.1093\/nar\/gkx1039","volume":"46","author":"J Li","year":"2018","unstructured":"Li J, Shi L, Zhang K, Zhang Y, Hu S, Zhao T, et al. VarCards: an integrated genetic and clinical database for coding variants in the human genome. Nucleic Acids Res. 2018;46(D1):D1039\u201348.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"9468_CR95","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.ab.2008.03.009","volume":"377","author":"Y Lin","year":"2008","unstructured":"Lin Y, Zhou J, Bi D, Chen P, Wang X, Liang S. Sodium-deoxycholate-assisted tryptic digestion and identification of proteolytically resistant proteins. Anal Biochem. 2008;377(2):259\u201366.","journal-title":"Anal Biochem"},{"issue":"7","key":"9468_CR96","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1038\/jid.2008.423","volume":"129","author":"E Linos","year":"2009","unstructured":"Linos E, Swetter SM, Cockburn MG, Colditz GA, Clarke CA, Drph MD. Increasing burden of melanoma in the United States. J Invest Dermatol. 2009;129(7):1666\u201374.","journal-title":"J Invest Dermatol"},{"key":"9468_CR97","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1007\/s00432-014-1738-8","volume":"140","author":"K Litovkin","year":"2014","unstructured":"Litovkin K, Joniau S, Lerut E, Laenen A, Gevaert O, Spahn M, et al. Methylation of PITX2, HOXD3, RASSF1 and TDRD1 predicts biochemical recurrence in high-risk prostate cancer. J Cancer Res Clin Oncol. 2014;140:1849\u201361.","journal-title":"J Cancer Res Clin Oncol"},{"key":"9468_CR98","doi-asserted-by":"publisher","unstructured":"Litovkin K, Van Eynde A, Joniau S, Lerut E, Laenen A, Gevaert T, et al. DNA methylation-guided prediction of clinical failure in high-risk prostate cancer. PLoS One. 2015;10(6):e0130651. https:\/\/doi.org\/10.1371\/journal.pone.0130651 .","DOI":"10.1371\/journal.pone.0130651"},{"issue":"5","key":"9468_CR99","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1021\/acs.jproteome.7b00841","volume":"17","author":"AA Lobas","year":"2018","unstructured":"Lobas AA, Pyatnitskiy MA, Chernobrovkin AL, Ilina IY, Karpov DS, Solovyeva EM, et al. Proteogenomics of malignant melanoma cell lines: the effect of stringency of exome data filtering on variant peptide identification in shotgun proteomics. J Proteome Res. 2018;17(5):1801\u201311.","journal-title":"J Proteome Res"},{"key":"9468_CR100","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.euprot.2015.01.002","volume":"6","author":"B Lombardi","year":"2015","unstructured":"Lombardi B, Rendell N, Edwards M, Katan M, Zimmermann JG. Evaluation of phosphopeptide enrichment strategies for quantitative TMT analysis of complex network dynamics in cancer-associated cell signalling. EuPA Open Proteom. 2015;6:10\u20135.","journal-title":"EuPA Open Proteom"},{"issue":"5","key":"9468_CR101","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.celrep.2013.10.041","volume":"5","author":"TY Low","year":"2013","unstructured":"Low TY, van Heesch S, van den Toorn H, Giansanti P, Cristobal A, Toonen P, et al. Quantitative and qualitative proteome characteristics extracted from in-depth integrated genomics and proteomics analysis. Cell Rep. 2013;5(5):1469\u201378.","journal-title":"Cell Rep"},{"key":"9468_CR102","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.media.2016.06.037","volume":"33","author":"A Madabhushi","year":"2016","unstructured":"Madabhushi A, Lee G. Image analysis and machine learning in digital pathology: challenges and opportunities. Med Image Anal. 2016;33:170\u20135.","journal-title":"Med Image Anal"},{"issue":"7","key":"9468_CR103","doi-asserted-by":"publisher","first-page":"3087","DOI":"10.1021\/pr400131r","volume":"12","author":"J Malm","year":"2013","unstructured":"Malm J, Danmyr P, Nilsson R, Appelqvist R, V\u00e9gv\u00e1ri \u00c1, Marko-Varga G. Blood plasma reference material: a global resource for proteomic research. J Proteome Res. 2013;12(7):3087\u201392.","journal-title":"J Proteome Res"},{"key":"9468_CR104","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s40169-015-0067-0","volume":"4","author":"J Malm","year":"2015","unstructured":"Malm J, Lindberg H, Erlinge D, Appelqvist R, Yakovleva M, Welinder C, et al. Semi-automated biobank sample processing with a 384 high density sample tube robot used in cancer and cardiovascular studies. Clin Transl Med. 2015;4:67.","journal-title":"Clin Transl Med"},{"key":"9468_CR105","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40169-018-0203-8","volume":"7","author":"J Malm","year":"2018","unstructured":"Malm J, Sugihara Y, Szasz M, Kwon HJ, Lindberg H, Appelqvist R, et al. Biobank integration of large-scale clinical and histopathology melanoma studies within the European Cancer Moonshot Lund Center. Clin Transl Med. 2018;7:28.","journal-title":"Clin Transl Med"},{"issue":"5","key":"9468_CR106","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1586\/epr.10.46","volume":"7","author":"B Manadas","year":"2010","unstructured":"Manadas B, Mendes VM, English J, Dunn MJ. Peptide fractionation in proteomics approaches. Expert Rev Proteomics. 2010;7(5):655\u201363.","journal-title":"Expert Rev Proteomics"},{"key":"9468_CR107","doi-asserted-by":"publisher","unstructured":"Marcell Szasz A, Malm J, Rezeli M, Sugihara Y, Betancourt LH, Rivas D, et al. Challenging the heterogeneity of disease presentation in malignant melanoma---impact on patient treatment. Cell Biol Toxicol. 2018;35(1):1\u201314. https:\/\/doi.org\/10.1007\/s10565-018-9446-9 .","DOI":"10.1007\/s10565-018-9446-9"},{"issue":"8","key":"9468_CR108","doi-asserted-by":"publisher","first-page":"2925","DOI":"10.1021\/pr070046s","volume":"6","author":"G Marko-Varga","year":"2007","unstructured":"Marko-Varga G, Ogiwara A, Nishimura T, Kawamura T, Fujii K, Kawakami T, et al. Personalized medicine and proteomics: lessons from non-small cell lung cancer. J Proteome Res. 2007;6(8):2925\u201335.","journal-title":"J Proteome Res"},{"issue":"1","key":"9468_CR109","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/2001-1326-1-8","volume":"1","author":"G Marko-Varga","year":"2012","unstructured":"Marko-Varga G, V\u00e9gv\u00e1ri A, Rezeli M, Prikk K, Ross P, Dahlb\u00e4ck M, et al. Understanding drug uptake and binding within targeted disease micro-environments in patients: a new tool for translational medicine. Clin Transl Med Springer. 2012a;1(1):8.","journal-title":"Clin Transl Med"},{"key":"9468_CR110","doi-asserted-by":"publisher","first-page":"5124","DOI":"10.1021\/pr300185k","volume":"11","author":"G Marko-Varga","year":"2012","unstructured":"Marko-Varga G, Vegvari A, Welinder C, Lindberg H, Rezeli M, Edula G, et al. Standardization and utilization of biobank resources in clinical protein science with examples of emerging applications. J Proteome Res. 2012b;11:5124\u201334.","journal-title":"J Proteome Res"},{"issue":"1","key":"9468_CR111","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s004280100480","volume":"440","author":"D Massi","year":"2002","unstructured":"Massi D, Franchi A, Borgognoni L, Paglierani M, Reali UM, Santucci M. Tumor angiogenesis as a prognostic factor in thick cutaneous malignant melanoma. A quantitative morphologic analysis. Virchows Arch. 2002;440(1):22\u20138.","journal-title":"Virchows Arch"},{"issue":"7","key":"9468_CR112","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/nmeth.2518","volume":"10","author":"P Mertins","year":"2013","unstructured":"Mertins P, Qiao JW, Patel J, Udeshi ND, Clauser KR, Mani DR, et al. Integrated proteomic analysis of post-translational modifications by serial enrichment. Nat Methods. 2013;10(7):634\u20137.","journal-title":"Nat Methods"},{"issue":"7605","key":"9468_CR113","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature18003","volume":"534","author":"P Mertins","year":"2016","unstructured":"Mertins P, Mani DR, Ruggles KV, Gillette MA, Clauser KR, Wang P, et al. Proteogenomics connects somatic mutations to signalling in breast cancer. Nature. 2016;534(7605):55\u201362.","journal-title":"Nature."},{"key":"9468_CR114","doi-asserted-by":"publisher","unstructured":"Misra BB, Langefeld CD, Olivier M, Cox LA. Integrated omics: tools, advances, and future approaches. J Mol Endocrinol. 2018. https:\/\/doi.org\/10.1530\/JME-18-0055 .","DOI":"10.1530\/JME-18-0055"},{"issue":"10","key":"9468_CR115","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1056\/NEJMoa0810699","volume":"361","author":"TS Mok","year":"2009","unstructured":"Mok TS, Wu Y-L, Thongprasert S, Yang C-H, Chu D-T, Saijo N, et al. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N Engl J Med. 2009;361(10):947\u201357.","journal-title":"N Engl J Med"},{"key":"9468_CR116","doi-asserted-by":"publisher","unstructured":"Montoni A, Robu M, Pouliot \u00c9, Shah GM. Resistance to PARP-inhibitors in cancer therapy. Front Pharmacol. 2013;4:18. https:\/\/doi.org\/10.3389\/fphar.2013.00018 .","DOI":"10.3389\/fphar.2013.00018"},{"issue":"17","key":"9468_CR117","doi-asserted-by":"publisher","first-page":"4130","DOI":"10.1002\/cncr.25148","volume":"116","author":"R Murali","year":"2010","unstructured":"Murali R, Shaw HM, Lai K, McCarthy SW, Quinn MJ, Stretch JR, et al. Prognostic factors in cutaneous desmoplastic melanoma. Cancer. 2010;116(17):4130\u20138.","journal-title":"Cancer."},{"key":"9468_CR118","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ctrv.2018.03.004","volume":"66","author":"A Musella","year":"2018","unstructured":"Musella A, Bardhi E, Marchetti C, Vertechy L, Santangelo G, Sassu C, et al. Rucaparib: an emerging parp inhibitor for treatment of recurrent ovarian cancer. Cancer Treat Rev. 2018;66:7\u201314.","journal-title":"Cancer Treat Rev"},{"issue":"11","key":"9468_CR119","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1038\/nmeth.3144","volume":"11","author":"AI Nesvizhskii","year":"2014","unstructured":"Nesvizhskii AI. Proteogenomics: concepts, applications and computational strategies. Nat Methods. 2014;11(11):1114\u201325.","journal-title":"Nat Methods"},{"key":"9468_CR120","doi-asserted-by":"publisher","unstructured":"Nogami N, Nishio M, Okamoto I, Enatsu S, Suzukawa K, Takai H, et al. Pemetrexed and carboplatin combination therapy followed by pemetrexed maintenance in Japanese patients with non-squamous non-small cell lung cancer: a subgroup analysis of elderly patients. Respir Investig. 2019;57(1):27\u201333. https:\/\/doi.org\/10.1016\/j.resinv.2018.09.003 .","DOI":"10.1016\/j.resinv.2018.09.003"},{"issue":"7","key":"9468_CR121","doi-asserted-by":"publisher","first-page":"e22062","DOI":"10.1371\/journal.pone.0022062","volume":"6","author":"F Nyberg","year":"2011","unstructured":"Nyberg F, Ogiwara A, Harbron CG, Kawakami T, Nagasaka K, Takami S, et al. Proteomic biomarkers for acute interstitial lung disease in gefitinib-treated Japanese lung cancer patients. Coonrod SA, editor. PLoS One. Public Library of Science. 2011;6(7):e22062.","journal-title":"PLoS One"},{"issue":"1","key":"9468_CR122","doi-asserted-by":"publisher","first-page":"32","DOI":"10.4103\/jpi.jpi_31_18","volume":"9","author":"TG Olsen","year":"2018","unstructured":"Olsen TG, Jackson BH, Feeser TA, Kent MN, Moad JC, Krishnamurthy S, et al. Diagnostic performance of deep learning algorithms applied to three common diagnoses in dermatopathology. J Pathol Inform. 2018;9(1):32.","journal-title":"J Pathol Inform"},{"key":"9468_CR123","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1517\/13543776.2013.768615","volume":"23","author":"G Papeo","year":"2013","unstructured":"Papeo G, Casale E, Montagnoli A, Cirla A. PARP inhibitors in cancer therapy : an update. Expert Opin Ther Pat. 2013;23:503\u201314.","journal-title":"Expert Opin Ther Pat"},{"key":"9468_CR124","doi-asserted-by":"publisher","unstructured":"Paska AV, Hudler P. Aberrant methylation patterns in cancer: a clinical view. Biochem Med. 2015;25(2):161\u201376. https:\/\/doi.org\/10.11613\/BM.2015.017 .","DOI":"10.11613\/BM.2015.017"},{"issue":"8","key":"9468_CR125","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.ejso.2011.05.007","volume":"37","author":"S Pasquali","year":"2011","unstructured":"Pasquali S, Mocellin S, Campana LG, Vecchiato A, Bonandini E, Montesco MC, et al. Maximizing the clinical usefulness of a nomogram to select patients candidate to sentinel node biopsy for cutaneous melanoma. Eur J Surg Oncol. 2011;37(8):675\u201380.","journal-title":"Eur J Surg Oncol"},{"key":"9468_CR126","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrd3078","volume":"9","author":"SM Paul","year":"2010","unstructured":"Paul SM, Mytelka DS, Dunwiddie CT, Persinger CC, Munos BH, Lindborg SR, et al. How to improve RD productivity: the pharmaceutical industry\u2019s grand challenge. Nat Rev Drug Discov. 2010;9:203\u201314.","journal-title":"Nat Rev Drug Discov"},{"issue":"5","key":"9468_CR127","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1021\/pr301146m","volume":"12","author":"PD Piehowski","year":"2013","unstructured":"Piehowski PD, Petyuk VA, Orton DJ, Xie F, Moore RJ, Ramirez-Restrepo M, et al. Sources of technical variability in quantitative LC\u2013MS proteomics: human brain tissue sample analysis. J Proteome Res American Chemical Society. 2013;12(5):2128\u201337.","journal-title":"J Proteome Res"},{"key":"9468_CR128","first-page":"173491","volume":"2012","author":"GE Pi\u00e9rard","year":"2012","unstructured":"Pi\u00e9rard GE, Humbert P, Quatresooz P. Tracking and treating malignant melanoma metastases. Dermatol Res Pract. Hindawi Limited. 2012;2012:173491.","journal-title":"Dermatol Res Pract"},{"issue":"8","key":"9468_CR129","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1038\/labinvest.2013.84","volume":"93","author":"JM Pimiento","year":"2013","unstructured":"Pimiento JM, Larkin EM, Smalley KS, Wiersma GL, Monks NR, Fedorenko IV, et al. Melanoma genotypes and phenotypes get personal. Lab Investig. 2013;93(8):858\u201367.","journal-title":"Lab Investig"},{"key":"9468_CR130","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1007\/s00280-013-2113-1","volume":"71","author":"R Plummer","year":"2013","unstructured":"Plummer R, Lorigan P, Steven N, Scott L, Middleton MR, Wilson RH, et al. A phase II study of the potent PARP inhibitor, Rucaparib (PF-01367338, AG014699), with temozolomide in patients with metastatic melanoma demonstrating evidence of chemopotentiation. Cancer Chemother Pharmacol. 2013;71:1191\u20139.","journal-title":"Cancer Chemother Pharmacol"},{"key":"9468_CR131","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1021\/acs.jproteome.6b00753","volume":"16","author":"H Post","year":"2017","unstructured":"Post H, Penning R, Fitzpatrick MA, Garrigues LB, Wu W, Macgillavry HD, et al. Robust, sensitive, and automated phosphopeptide enrichment optimized for low sample amounts applied to primary hippocampal neurons. J Proteome Res. 2017;16:728\u201337.","journal-title":"J Proteome Res"},{"key":"9468_CR132","doi-asserted-by":"publisher","first-page":"117693511772572","DOI":"10.1177\/1176935117725727","volume":"16","author":"B Ray","year":"2017","unstructured":"Ray B, Liu W, Feny\u00f6 D. Adaptive multiview nonnegative matrix factorization algorithm for integration of multimodal biomedical data. Cancer Informat. 2017;16:117693511772572.","journal-title":"Cancer Informat"},{"issue":"3","key":"9468_CR133","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1001\/archdermatol.2009.379","volume":"146","author":"DS Rigel","year":"2010","unstructured":"Rigel DS. Trends in dermatology: melanoma incidence. Arch Dermatol American Medical Association. 2010;146(3):318.","journal-title":"Arch Dermatol"},{"key":"9468_CR134","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1056\/NEJMoa1412690","volume":"372","author":"C Robert","year":"2015","unstructured":"Robert C, Karaszewska B, Schachter J, Rutkowski P, Mackiewicz A, Stroiakovski D, et al. Improved overall survival in melanoma with combined dabrafenib and trametinib. N Engl J Med. 2015;372:30\u20139.","journal-title":"N Engl J Med"},{"issue":"2","key":"9468_CR135","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.ccell.2017.07.003","volume":"32","author":"AG Robertson","year":"2017","unstructured":"Robertson AG, Shih J, Yau C, Gibb EA, Oba J, Mungall KL, et al. Integrative analysis identifies four molecular and clinical subsets in uveal melanoma. Cancer Cell. 2017;32(2):204\u2013220.e15.","journal-title":"Cancer Cell"},{"issue":"6","key":"9468_CR136","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1172\/JCI43424","volume":"120","author":"M R\u00f6cken","year":"2010","unstructured":"R\u00f6cken M. Early tumor dissemination, but late metastasis: insights into tumor dormancy. J Clin Invest. 2010;120(6):1800\u20133.","journal-title":"J Clin Invest"},{"key":"9468_CR137","doi-asserted-by":"publisher","unstructured":"Rodr\u00edguez-Cerdeira C, Molares-Vila A, Carnero-Gregorio M, Corbal\u00e1n-Rivas A. Recent advances in melanoma research via \u201comics\u201d platforms. J Proteomics. 2018;188:152\u201366. https:\/\/doi.org\/10.1016\/j.jprot.2017.11.005 .","DOI":"10.1016\/j.jprot.2017.11.005"},{"issue":"11","key":"9468_CR138","doi-asserted-by":"publisher","first-page":"e1005752","DOI":"10.1371\/journal.pcbi.1005752","volume":"13","author":"F Rohart","year":"2017","unstructured":"Rohart F, Gautier B, Singh A, L\u00ea Cao K-A. mixOmics: an R package for \u2018omics feature selection and multiple data integration. Schneidman D, editor. PLoS Comput Biol. Public Library of Science. 2017;13(11):e1005752.","journal-title":"PLoS Comput Biol"},{"key":"9468_CR139","doi-asserted-by":"publisher","unstructured":"Salemi R, Falzone L, Madonna G, Polesel J, Cin\u00e0 D, Mallardo D, et al. MMP-9 as a candidate marker of response to BRAF inhibitors in melanoma patients with BRAFV600Emutation detected in circulating-free DNA. Front Pharmacol. 2018;9:856. https:\/\/doi.org\/10.3389\/fphar.2018.00856 .","DOI":"10.3389\/fphar.2018.00856"},{"issue":"1","key":"9468_CR140","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.celrep.2018.03.086","volume":"23","author":"J Saltz","year":"2018","unstructured":"Saltz J, Gupta R, Hou L, Kurc T, Singh P, Nguyen V, et al. Spatial organization and molecular correlation of tumor-infiltrating lymphocytes using deep learning on pathology images. Cell Rep. 2018;23(1):181\u2013193.e7.","journal-title":"Cell Rep"},{"issue":"4","key":"9468_CR141","first-page":"572","volume":"7","author":"A Sandru","year":"2014","unstructured":"Sandru A, Voinea S, Panaitescu E, Blidaru A. Survival rates of patients with metastatic malignant melanoma. J Med Life. 2014;7(4):572\u20136.","journal-title":"J Med Life"},{"key":"9468_CR142","doi-asserted-by":"publisher","unstructured":"Scaini MC, Pigozzo J, Pizzi M, Manicone M, Chiarion-Sileni V, Zambenedetti P, et al. Clonal heterogeneity of melanoma in a paradigmatic case study: future prospects for circulating melanoma cells. Melanoma Res. 2019;29(1):89\u201394. https:\/\/doi.org\/10.1097\/CMR.0000000000000510 .","DOI":"10.1097\/CMR.0000000000000510"},{"issue":"11","key":"9468_CR143","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1038\/ncb3638","volume":"19","author":"K Schlacher","year":"2017","unstructured":"Schlacher K. PARPi focus the spotlight on replication fork protection in cancer. Nat Cell Biol Nature Publishing Group. 2017;19(11):1309\u201310.","journal-title":"Nat Cell Biol"},{"key":"9468_CR144","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nbt.3130","volume":"33","author":"C Sch\u00f6lz","year":"2015","unstructured":"Sch\u00f6lz C, Weinert BT, Wagner SA, Beli P, Miyake Y, Qi J, et al. Acetylation site specificities of lysine deacetylase inhibitors in human cells. Nat Biotechnol. 2015;33:415\u201323.","journal-title":"Nat Biotechnol"},{"issue":"7347","key":"9468_CR145","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature10098","volume":"473","author":"B Schwanh\u00e4usser","year":"2011","unstructured":"Schwanh\u00e4usser B, Busse D, Li N, Dittmar G, Schuchhardt J, Wolf J, et al. Global quantification of mammalian gene expression control. Nature. 2011;473(7347):337\u201342.","journal-title":"Nature."},{"key":"9468_CR146","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/nrc3066","volume":"11","author":"H Schwarzenbach","year":"2011","unstructured":"Schwarzenbach H, Hoon DSB, Pantel K. Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer. 2011;11:426\u201337.","journal-title":"Nat Rev Cancer"},{"key":"9468_CR147","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1016\/j.celrep.2014.07.036","volume":"8","author":"K Sharma","year":"2014","unstructured":"Sharma K, D\u2019Souza RCJ, Tyanova S, Schaab C, Wi\u015bniewski JR, Cox J, et al. Ultradeep human phosphoproteome reveals a distinct regulatory nature of Tyr and Ser\/Thr-based signaling. Cell Rep. 2014;8:1583\u201394.","journal-title":"Cell Rep"},{"key":"9468_CR148","doi-asserted-by":"publisher","first-page":"772","DOI":"10.15252\/msb.20145450","volume":"10","author":"MA Smit","year":"2014","unstructured":"Smit MA, Maddalo G, Greig K, Raaijmakers LM, Possik PA, van Breukelen B, et al. ROCK1 is a potential combinatorial drug target for BRAF mutant melanoma. Mol Syst Biol. 2014;10:772.","journal-title":"Mol Syst Biol"},{"issue":"2","key":"9468_CR149","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3109\/00313028509063763","volume":"17","author":"K S\u00f8ndergaard","year":"1985","unstructured":"S\u00f8ndergaard K. Biological behaviour of cutaneous malignant melanomas. Pathology. 1985;17(2):255\u20137.","journal-title":"Pathology."},{"issue":"8","key":"9468_CR150","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/S1470-2045(10)70024-3","volume":"11","author":"DC Strauss","year":"2010","unstructured":"Strauss DC, Thomas JM. Transmission of donor melanoma by organ transplantation. Lancet Oncol. 2010;11(8):790\u20136.","journal-title":"Lancet Oncol"},{"key":"9468_CR151","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1002\/pmic.201300476","volume":"14","author":"Y Sugihara","year":"2014","unstructured":"Sugihara Y, V\u00e9gv\u00e1ri \u00c1, Welinder C, J\u00f6nsson G, Ingvar C, Lundgren L, et al. A new look at drugs targeting malignant melanoma-An application for mass spectrometry imaging. Proteomics. 2014;14:1963\u201370.","journal-title":"Proteomics"},{"key":"9468_CR152","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40169-018-0201-x","volume":"7","author":"Y Sugihara","year":"2018","unstructured":"Sugihara Y, Rivas D, Malm J, Szasz M, Kwon H, Baldetorp B, et al. Endogenous expression mapping of malignant melanoma by mass spectrometry imaging. Clin Transl Med. 2018;7:22.","journal-title":"Clin Transl Med"},{"issue":"9","key":"9468_CR153","doi-asserted-by":"publisher","first-page":"4398","DOI":"10.1021\/ac303658t","volume":"85","author":"F Suits","year":"2013","unstructured":"Suits F, Fehniger TE, V\u00e9gv\u00e1ri \u00c1, Marko-Varga G, Horvatovich P. Correlation queries for mass spectrometry imaging. Anal Chem. 2013;85(9):4398\u2013404.","journal-title":"Anal Chem"},{"key":"9468_CR154","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.semcdb.2016.08.026","volume":"64","author":"AM Sz\u00e1sz","year":"2017","unstructured":"Sz\u00e1sz AM, Gy\u0151rffy B, Marko-Varga G. Cancer heterogeneity determined by functional proteomics. Semin Cell Dev Biol. 2017;64:132\u201342.","journal-title":"Semin Cell Dev Biol"},{"key":"9468_CR155","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1146\/annurev.biochem.78.070907.103047","volume":"78","author":"MK Tarrant","year":"2009","unstructured":"Tarrant MK, Cole PA. The chemical biology of protein phosphorylation. Annu Rev Biochem. 2009;78:797\u2013825.","journal-title":"Annu Rev Biochem"},{"key":"9468_CR156","doi-asserted-by":"publisher","unstructured":"Thingholm TE, Larsen MR. Phosphopeptide enrichment by immobilized metal affinity chromatography. Methods Mol Biol. 2016a;1355:123\u201333. https:\/\/doi.org\/10.1007\/978-1-4939-3049-4_8 .","DOI":"10.1007\/978-1-4939-3049-4_8"},{"key":"9468_CR157","doi-asserted-by":"publisher","unstructured":"Thingholm TE, Larsen MR. The use of titanium dioxide for selective enrichment of phosphorylated peptides. Methods Mol Biol. 2016b;1355:135\u201346. https:\/\/doi.org\/10.1007\/978-1-4939-3049-4_9 .","DOI":"10.1007\/978-1-4939-3049-4_9"},{"issue":"4","key":"9468_CR158","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","volume":"48","author":"V Thorsson","year":"2018","unstructured":"Thorsson V, Gibbs DL, Brown SD, Wolf D, Bortone DS, Ou Yang T-H, et al. The immune landscape of cancer. Immunity. 2018;48(4):812\u2013830.e14.","journal-title":"Immunity"},{"issue":"4","key":"9468_CR159","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1111\/bph.12990","volume":"172","author":"S Torok","year":"2015","unstructured":"Torok S, Vegvari A, Rezeli M, Fehniger TE, Tovari J, Paku S, et al. Localization of sunitinib, its metabolites and its target receptors in tumour-bearing mice: a MALDI-MS imaging study. Br J Pharmacol. 2015;172(4):1148\u201363.","journal-title":"Br J Pharmacol"},{"issue":"2","key":"9468_CR160","doi-asserted-by":"publisher","first-page":"400","DOI":"10.7150\/thno.16767","volume":"7","author":"S Torok","year":"2017","unstructured":"Torok S, Rezeli M, Kelemen O, Vegvari A, Watanabe K, Sugihara Y, et al. Limited tumor tissue drug penetration contributes to primary resistance against angiogenesis inhibitors. Theranostics. 2017;7(2):400\u201312.","journal-title":"Theranostics."},{"key":"9468_CR161","doi-asserted-by":"publisher","unstructured":"Tringali C, Silvestri I, Testa F, Baldassari P, Anastasia L, Mortarini R, et al. Molecular subtyping of metastatic melanoma based on cell ganglioside metabolism profiles. 2014;14:560. https:\/\/doi.org\/10.1186\/1471-2407-14-560 .","DOI":"10.1186\/1471-2407-14-560"},{"issue":"12","key":"9468_CR162","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1002\/(SICI)1097-0142(19970615)79:12<2361::AID-CNCR10>3.0.CO;2-P","volume":"79","author":"H Tsao","year":"1997","unstructured":"Tsao H, Cosimi AB, Sober AJ. Ultra-late recurrence (15 years or longer) of cutaneous melanoma. Cancer Wiley-Blackwell. 1997;79(12):2361\u201370.","journal-title":"Cancer"},{"issue":"1\u20132","key":"9468_CR163","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.imlet.2011.04.008","volume":"139","author":"WW Tseng","year":"2011","unstructured":"Tseng WW, Leong SPL. Long-term survivors after immunotherapy for metastatic melanoma. Immunol Lett Elsevier. 2011;139(1\u20132):117\u20138.","journal-title":"Immunol Lett"},{"key":"9468_CR164","doi-asserted-by":"crossref","unstructured":"Ubersax JA, Ferrell JE. Mechanisms of specificity in protein phosphorylation. Nat Rev Mol Cell Biol. 2007;8(7):530\u201341.","DOI":"10.1038\/nrm2203"},{"issue":"23","key":"9468_CR165","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1056\/NEJMoa1000584","volume":"363","author":"CD Raamsdonk Van","year":"2010","unstructured":"Van Raamsdonk CD, Griewank KG, Crosby MB, Garrido MC, Vemula S, Wiesner T, et al. Mutations in GNA11 in uveal melanoma. N Engl J Med. 2010;363(23):2191\u20139.","journal-title":"N Engl J Med"},{"issue":"5","key":"9468_CR166","doi-asserted-by":"publisher","first-page":"3278","DOI":"10.1021\/cr100011x","volume":"110","author":"A V\u00e9gv\u00e1ri","year":"2010","unstructured":"V\u00e9gv\u00e1ri A, Marko-Varga G. Clinical protein science and bioanalytical mass spectrometry with an emphasis on lung cancer. Chem Rev American Chemical Society. 2010;110(5):3278\u201398.","journal-title":"Chem Rev"},{"key":"9468_CR167","unstructured":"V\u00e9gv\u00e1ri \u00c1, Rezeli M, D\u00f6me B, Fehniger TE, Marko-Varga G. Translation science for targeted personalized medicine treatments. Science\/AAAS. S. Sanders Ed., editor. Sel. Present. from 2011 Sino-American Symp. Clin. Transl. Med. S. Sanders Ed. (Science\/AAAS, Washington, DC). Washington DC; 2011;36\u20137."},{"key":"9468_CR168","doi-asserted-by":"crossref","unstructured":"V\u00e9gv\u00e1ri A, Fehniger TE, Dahlback M, Marko-Varga G, Strupat K. In vivo Distribution of Tiotropium in a Rodent Model Utilizing AP-SMALDI Mass Spectrometry Imaging. Curr Anal Chem. 2017;13(3):182\u20136.","DOI":"10.2174\/1573411012666160211235640"},{"key":"9468_CR169","doi-asserted-by":"publisher","unstructured":"Vreman RA, Bouvy JC, Bloem LT, H\u00f6vels AM, Mantel-Teeuwisse AK, Leufkens HGM, et al. Weighing of evidence by health technology assessment bodies: retrospective study of reimbursement recommendations for conditionally approved drugs. Clin Pharmacol Ther. 2018;105(3):684\u201391. https:\/\/doi.org\/10.1002\/cpt.1251 .","DOI":"10.1002\/cpt.1251"},{"issue":"7","key":"9468_CR170","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1002\/elps.11501601185","volume":"16","author":"VC Wasinger","year":"1995","unstructured":"Wasinger VC, Cordwell SJ, Cerpa-Poljak A, Yan JX, Gooley AA, Wilkins MR, et al. Progress with gene-product mapping of the Mollicutes: mycoplasma genitalium. Electrophoresis. 1995;16(7):1090\u20134.","journal-title":"Electrophoresis."},{"key":"9468_CR171","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1172\/JCI69740","volume":"124","author":"DJ Weisenberger","year":"2014","unstructured":"Weisenberger DJ. Characterizing DNA methylation alterations from the cancer genome atlas. J Clin Invest. 2014;124:17\u201323.","journal-title":"J Clin Invest"},{"issue":"4","key":"9468_CR172","doi-asserted-by":"publisher","first-page":"e0176167","DOI":"10.1371\/journal.pone.0176167","volume":"12","author":"C Welinder","year":"2017","unstructured":"Welinder C, Paw\u0142owski K, Szasz AM, Yakovleva M, Sugihara Y, Malm J, et al. Correlation of histopathologic characteristics to protein expression and function in malignant melanoma. Zmijewski M, editor. PLoS One. Public Library of Science. 2017;12(4):e0176167.","journal-title":"PLoS One"},{"key":"9468_CR173","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1038\/jid.2011.142","volume":"131","author":"C Wels","year":"2011","unstructured":"Wels C, Joshi S, Koefinger P, Bergler H, Schaider H. Transcriptional activation of ZEB1 by slug leads to cooperative regulation of the epithelial-mesenchymal transition-like phenotype in melanoma. J Invest Dermatol. 2011;131:1877\u201385.","journal-title":"J Invest Dermatol"},{"key":"9468_CR174","unstructured":"WHO | Skin cancers. WHO. World Health Organization; 2017."},{"key":"9468_CR175","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/02648725.1996.10647923","volume":"13","author":"MR Wilkins","year":"1996","unstructured":"Wilkins MR, Sanchez JC, Gooley AA, Appel RD, Humphery-Smith I, Hochstrasser DF, et al. Progress with proteome projects: why all proteins expressed by a genome should be identified and how to do it. Biotechnol Genet Eng Rev. 1996;13:19\u201350.","journal-title":"Biotechnol Genet Eng Rev"},{"issue":"5","key":"9468_CR176","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nmeth.1322","volume":"6","author":"JR Wi\u015bniewski","year":"2009","unstructured":"Wi\u015bniewski JR, Zougman A, Nagaraj N, Mann M. Universal sample preparation method for proteome analysis. Nat Methods. 2009;6(5):359\u201362.","journal-title":"Nat Methods"},{"issue":"4","key":"9468_CR177","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1245\/ASO.2005.05.016","volume":"12","author":"SL Wong","year":"2005","unstructured":"Wong SL, Kattan MW, McMasters KM, Coit DG. A nomogram that predicts the presence of sentinel node metastasis in melanoma with better discrimination than the American Joint Committee on CancerStaging system. Ann Surg Oncol. 2005;12(4):282\u20138.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"9468_CR178","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.gpb.2015.01.005","volume":"13","author":"Y Yang","year":"2015","unstructured":"Yang Y, Dong X, Xie B, Ding N, Chen J, Li Y, et al. Databases and web tools for cancer genomics study. Genomics Proteomics Bioinformatics. 2015;13(1):46\u201350.","journal-title":"Genomics Proteomics Bioinformatics"},{"issue":"13","key":"9468_CR179","doi-asserted-by":"publisher","first-page":"i401","DOI":"10.1093\/bioinformatics\/btr206","volume":"27","author":"S Zhang","year":"2011","unstructured":"Zhang S, Li Q, Liu J, Zhou XJ. A novel computational framework for simultaneous integration of multiple types of genomic data to identify microRNA-gene regulatory modules. Bioinformatics. 2011;27(13):i401\u20139.","journal-title":"Bioinformatics."},{"issue":"19","key":"9468_CR180","doi-asserted-by":"publisher","first-page":"9379","DOI":"10.1093\/nar\/gks725","volume":"40","author":"S Zhang","year":"2012","unstructured":"Zhang S, Liu C-C, Li W, Shen H, Laird PW, Zhou XJ. Discovery of multi-dimensional modules by integrative analysis of cancer genomic data. Nucleic Acids Res. 2012;40(19):9379\u201391.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"9468_CR181","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1021\/acs.jproteome.6b00505","volume":"16","author":"M Zhang","year":"2017","unstructured":"Zhang M, Wang B, Xu J, Wang X, Xie L, Zhang B, et al. CanProVar 2.0: an updated database of human cancer proteome variation. J. Proteome Res. 2017;16(2):421\u201332.","journal-title":"Proteome Res"},{"issue":"1","key":"9468_CR182","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/s41467-018-03311-y","volume":"9","author":"Y Zhu","year":"2018","unstructured":"Zhu Y, Orre LM, Johansson HJ, Huss M, Boekel J, Vesterlund M, et al. Discovery of coding regions in the human genome by integrated proteogenomics analysis workflow. Nat Commun. 2018;9(1):903.","journal-title":"Nat Commun"},{"issue":"12","key":"9468_CR183","doi-asserted-by":"publisher","first-page":"19780","DOI":"10.18632\/oncotarget.15540","volume":"8","author":"L Ziani","year":"2017","unstructured":"Ziani L, Safta-Saadoun TB, Gourbeix J, Cavalcanti A, Robert C, Favre G, et al. Melanoma-associated fibroblasts decrease tumor cell susceptibility to NK cell-mediated killing through matrix-metalloproteinases secretion. Oncotarget. 2017;8(12):19780\u201394.","journal-title":"Oncotarget."}],"container-title":["Cell Biology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10565-019-09468-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10565-019-09468-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10565-019-09468-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,2]],"date-time":"2020-12-02T06:29:58Z","timestamp":1606890598000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10565-019-09468-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,21]]},"references-count":183,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["9468"],"URL":"https:\/\/doi.org\/10.1007\/s10565-019-09468-6","relation":{},"ISSN":["0742-2091","1573-6822"],"issn-type":[{"value":"0742-2091","type":"print"},{"value":"1573-6822","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,21]]},"assertion":[{"value":"4 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}